A randomised double-blind placebo-controlled single escalating dose study of the safety and efficacy (reduction of signs and symptoms of rheumatoid arthritis) during treatment with BiP versus placebo in combination with methotrexate in patients with moderate to severe active rheumatoid arthritis

Project: Research

Project Details

Effective start/end date1/02/20083/10/2015

Collaborative partners


  • Arthritis Research UK: £412,230.00
  • Arthritis Research UK: £32,701.00